Rollins CapEx increased by 24.7% to $7.14M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.3%, from $6.78M to $7.14M. Over 4 years (FY 2021 to FY 2025), CapEx shows relatively stable performance with a 0.8% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.40M | $6.80M | $7.16M | $8.00M | $7.89M | $7.04M | $7.71M | $7.64M | $6.78M | $6.87M | $11.19M | $7.17M | $8.70M | $7.52M | $4.18M | $6.78M | $7.08M | $8.50M | $5.73M | $7.14M |
| QoQ Change | — | +25.9% | +5.3% | +11.6% | -1.4% | -10.7% | +9.5% | -0.9% | -11.3% | +1.4% | +62.9% | -35.9% | +21.3% | -13.5% | -44.4% | +62.1% | +4.4% | +20.2% | -32.7% | +24.7% |
| YoY Change | — | — | — | — | +46.0% | +3.5% | +7.6% | -4.5% | -14.1% | -2.4% | +45.1% | -6.1% | +28.4% | +9.5% | -62.6% | -5.4% | -18.6% | +13.0% | +36.9% | +5.3% |